NEW YORK, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated…
Preclinical Studies Confirmed BP1001-A Mechanism of Action and Therapeutic Potential in Obesity and Type 2 DiabetesHOUSTON, Dec. 19, 2024 (GLOBE…
– Completed US$7.7 million financing and reverse takeover to take Company public – Chinese partner achieved regulatory approval, setting stage for…
Phio's Lead Compound PH-762 demonstrates encouraging safety profile in 2nd cohort with recommendation to escalate to next dose concentrationMarlborough, Massachusetts--(Newsfile…
Visit Hisense at Booth 16625 in Central Hall at the Las Vegas Convention Center to see live demonstrations and a…
VANCOUVER, BC / ACCESSWIRE / December 19, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience…
Collaboration with Kure.ai to develop ultrafast CAR-T manufacturing process for Hemogenyx Pharmaceuticals' AML Treatment LONDON, UNITED KINGDOM / ACCESSWIRE /…
Hefty Seed Company Among the First Distribution Partners to Deliver Advanced Nitrogen Solutions Across the Midwest and Plains AMES, Iowa…
Health Net Assisting Members During State of Emergency SACRAMENTO, Calif., Dec. 18, 2024 /PRNewswire/ -- In response to Gov. Gavin…
Real-time information aligns with first-party diagnostics to remediate data decay and reveal pristine insights into medical information NEW YORK, Dec.…